comparemela.com
Home
Live Updates
Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for ... : comparemela.com
Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for ...
Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February
Related Keywords
Northwestern University
,
Illinois
,
United States
,
New York
,
Paris
,
France General
,
France
,
Evanston
,
Regina Jehle
,
Marla Dubinsky
,
Marlac Dubinsky
,
Parambir Dulai
,
Parambirs Dulai
,
Patrick Malloy
,
Steering Committee
,
Twitter
,
Digestive Health Foundation Biorepository
,
Division Of Pediatric
,
Icahn School Of Medicine At Mount Sinai
,
Division Of Gastroenterology
,
Abivax Communications
,
Linkedin
,
Euronext Paris
,
Icahn School
,
Mount Sinai
,
Mount Sinai Kravis Children
,
Associate Professor
,
Precision Medicine
,
Digestive Health Foundation
,
Business
,
comparemela.com © 2020. All Rights Reserved.